It takes a village for health systems to fully benefit from high-cost specialty medications, according to a new report from Vizient forecasting key healthcare system trends in 2025.
To maximize the revenue from specialty pharmacy drugs—including cell and gene therapies that can cost more than $1 million per dose—pharmacy leaders need to “[enhance] patient access” and work “as a multidisciplinary team to identify systemwide efficiencies for these